KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aehr Test Systems (AEHR) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Aehr Test Systems (AEHR) over the last 16 years, with Q4 2025 value amounting to $30.8 million.

  • Aehr Test Systems' Cash & Equivalents fell 428.97% to $30.8 million in Q4 2025 from the same period last year, while for Nov 2025 it was $30.8 million, marking a year-over-year decrease of 428.97%. This contributed to the annual value of $24.5 million for FY2025, which is 5010.27% down from last year.
  • As of Q4 2025, Aehr Test Systems' Cash & Equivalents stood at $30.8 million, which was down 428.97% from $22.7 million recorded in Q3 2025.
  • Aehr Test Systems' 5-year Cash & Equivalents high stood at $51.0 million for Q3 2023, and its period low was $4.6 million during Q2 2021.
  • In the last 5 years, Aehr Test Systems' Cash & Equivalents had a median value of $31.2 million in 2022 and averaged $29.6 million.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first surged by 91568.57% in 2021, then crashed by 5010.27% in 2025.
  • Aehr Test Systems' Cash & Equivalents (Quarter) stood at $35.0 million in 2021, then tumbled by 46.12% to $18.9 million in 2022, then soared by 167.64% to $50.5 million in 2023, then tumbled by 36.22% to $32.2 million in 2024, then fell by 4.29% to $30.8 million in 2025.
  • Its Cash & Equivalents was $30.8 million in Q4 2025, compared to $22.7 million in Q3 2025 and $24.5 million in Q2 2025.